Methylphenidate enhances neural stem cell differentiation

BACKGROUND: The psychostimulant methylphenidate (MPH) is the first choice of drug treatment in Attention-Deficit/Hyperactivity Disorder (ADHD). Since therapy often begins at a time when the brain is still developing and the long-term consequences of MPH are still not fully clarified, we examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartl, Jasmin, Mori, Takatoshi, Riederer, Peter, Ozawa, Hiroki, Grünblatt, Edna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224010/
https://www.ncbi.nlm.nih.gov/pubmed/25408898
http://dx.doi.org/10.1186/2049-9256-1-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224010/
https://www.ncbi.nlm.nih.gov/pubmed/25408898
http://dx.doi.org/10.1186/2049-9256-1-5

Ejemplares similares